| FCGBX | RIRBX | FCGBX / RIRBX | |
| Total Expense Ratio | 1.96 | 1.36 | 144% |
| Annual Report Gross Expense Ratio | 2.01 | 1.36 | 148% |
| Fund Existence | 14 years | 23 years | - |
| Gain YTD | 23.642 | 18.460 | 128% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 314M | 121B | 0% |
| Annual Yield % from dividends | 2.79 | 2.20 | 127% |
| Returns for 1 year | 19.85 | 14.13 | 140% |
| Returns for 3 years | 42.38 | 37.22 | 114% |
| Returns for 5 years | 22.10 | 46.11 | 48% |
| Returns for 10 years | 21.70 | 62.48 | 35% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRIEX | 29.29 | 0.17 | +0.58% |
| Nuveen International Eq Idx Retire | |||
| SMEIX | 19.61 | 0.02 | +0.10% |
| Invesco Small Cap Equity R5 | |||
| FHCCX | 43.47 | N/A | N/A |
| Fidelity Advisor Health Care C | |||
| LRSRX | 13.47 | -0.01 | -0.07% |
| Lord Abbett Small Cap Value R3 | |||
| ETNEX | 14.72 | -0.07 | -0.47% |
| Eventide Exponential Technologies N | |||